Compare Ketrosden Triasmitra Tbk. (KETR) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ketrosden Triasmitra Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Ketrosden Triasmitra Tbk. trades at Rp540 (market cap 1.49T, 24.08M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Ketrosden Triasmitra Tbk. is far larger — about 2.6× UBC Medical Indonesia Tbk.'s market cap, and Ketrosden Triasmitra Tbk. is more actively traded (24.08M versus 3.48M). Which is the better fit depends on your goals.
| KETR | LABS | |
|---|---|---|
Market Cap | 1.49T | 576.7B |
Volume | 24.08M | 3.48M |
Lot | 240.78K | 34.82K |
Turnover | 13.09B | 522.79M |
Average Price | 543.76 | 150.13 |
Value | 13.09B | 522.79M |
Indicative Equilibrium Price | 540 | 148 |
Indicative Equilibrium Volume | 1.91K | 350 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ketrosden Triasmitra Tbk.
PT Ketrosden Triasmitra Tbk was established base on Notarial Deed No.179 of Pudji Redjeki Irawati S.H., dated November 25, 1994.
Read more on KETR →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
